| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 8-Bromotheophylline (400 mg) |
8-溴茶堿 |
10381-75-6 |
詳細(xì)
|
| Vildagliptin Impurity 53 |
維格列汀雜質(zhì)53 |
700376-84-7 |
詳細(xì)
|
| 1,3-Dinitroglycerin (2 ampules x 1 mL) |
甘油1,3-二硝酸酯 |
623-87-0 |
詳細(xì)
|
| 7-Chloromethyl 17-Epidrospirenone (25 mg) |
7-ChloroMethyl 17R-Drospirenone |
932388-89-1 |
詳細(xì)
|
| (R)-1-Boc-3-Aminopiperidine |
(R)-1-叔丁氧羰基-3-氨基哌啶（利奈唑胺雜質(zhì)） |
625471-18-3 |
詳細(xì)
|
| Linagliptin Impurity S |
利格列汀雜質(zhì)S |
668273-74-3 |
詳細(xì)
|
| (+)-Catechin (25 mg) |
(+)-兒茶素 |
154-23-4 |
詳細(xì)
|
| 2,3-Butanedithiol (3 x 1 g) |
2,3-丁二硫醇 |
4532-64-3 |
詳細(xì)
|
| (-)-Epicatechin (50 mg) |
表兒茶素 |
490-46-0 |
詳細(xì)
|
| 2-Propenoic acid, 2-[formyl[(1R)-1-phenylethyl]amino]-3-hydroxy-, ethyl ester |
(R,E)-3-羥基-2-(N-(1-苯乙基)甲酰胺基)丙烯酸乙酯 |
1357291-60-1 |
詳細(xì)
|
| 1-Cyclopentyl-4-nitrosopiperazine (CPNP) Solution (1 mL (1 mg/mL)) (1-Cyclopentyl-4-nitrosopiperazine) |
1-環(huán)戊基-4-亞硝基哌嗪 |
61379-66-6 |
詳細(xì)
|
| (2S)-1-(2,2,2-trifluoroacetyl)pyrrolidine-2-carbonitrile; 2-Pyrrolidinecarbonitrile, 1-(trifluoroacetyl)-, (S)- (9CI) |
維格列汀的雜質(zhì) |
151258-26-3 |
詳細(xì)
|
| 6Beta-Hydroxybudesonide (25 mg) ((2R,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2,7-dihydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one) |
6-Β-羥基布地奈德 |
88411-77-2 |
詳細(xì)
|
| XYLOTAXOL, 7-(RG) |
7-木糖基紫杉醇 |
90332-66-4 |
詳細(xì)
|
| vildagliptin Impurity Q |
維格列汀雜質(zhì)Q |
1803168-08-2 |
詳細(xì)
|
| Vildagliptin Impurity 42 |
維達(dá)列汀雜質(zhì)42 |
65732-69-6 |
詳細(xì)
|
| 1-Ethoxy-2-Methylpropane (3 x 0.2 mL) |
異丁醚 |
627-02-1 |
詳細(xì)
|
| (1S,2R)-Eliglustat Diastereomer (25 mg) (N-[(1S,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide) |
ELIGLUSTAT IMPURITY 1(ELIGLUSTAT RS-ISOMER) |
1092472-65-5 |
詳細(xì)
|
| 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid (50 mg) |
5-氨基-3-羧基-2,4,6-三碘-N-甲基苯甲酰胺 |
2280-89-9 |
詳細(xì)
|
| tert-butyl (R)-(1-((4-methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate |
利格列汀雜質(zhì)C |
2514949-81-4 |
詳細(xì)
|
| 2'-Fucosyllactose (200 mg) |
2'-巖藻糖基乳糖 |
41263-94-9 |
詳細(xì)
|
| 4-Hydroxyisoleucine (35 mg) |
4-羥基-L-異亮氨酸 |
781658-23-9 |
詳細(xì)
|
| 1,6-anhydro-D-glucose (50 mg) |
1,6-脫水-BETHA-D-葡萄糖 |
498-07-7 |
詳細(xì)
|
| (R)-1-(2-chloroacetyl)pyrrolidine-2-carboxaMide |
R-1-氯乙?；?2-氰基吡咯烷（維格列汀雜質(zhì)） |
1211679-98-9 |
詳細(xì)
|
| 6-Methylnicotinic Acid (50 mg) |
6-甲基煙酸 |
3222-47-7 |
詳細(xì)
|
| 2,4,6-Tritertbutylphenol (25 mg) (2,4,6-Tri-tert-butylphenol) |
2,4,6-三叔丁基苯酚 |
732-26-3 |
詳細(xì)
|
| Linagliptin Impurity 29 |
利拉利汀雜質(zhì)29 |
2074688-82-5 |
詳細(xì)
|
| 2,6-Dichlorophenylacetic Acid |
2,6-二氯苯乙酸 |
6575-24-2 |
詳細(xì)
|
| 6-O-Methylerythromycin A 9-(O-methyloxime) (25 mg) |
克拉霉素EP雜質(zhì)G |
107216-09-1 |
詳細(xì)
|
| 5'-Cytidylic Acid (500 mg) |
5'-胞苷酸 |
63-37-6 |
詳細(xì)
|
| Olmesartan Medoxomil Impurity O |
奧美沙坦酯雜質(zhì)O |
189400-21-3 |
詳細(xì)
|
| 2-Oxo Clopidogrel (Mixture of Diastereomers) (10 mg) (methyl 2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate) |
甲基(2-氯苯基)(2-氧代-2,6,7,7ALPHA-四氫噻吩并[3,2-C]吡啶-5(4H)-基)乙酸酯 |
109904-27-0 |
詳細(xì)
|
| Acetamide, N-(2-acetylphenyl)-2,2-dichloro- |
利格列汀雜質(zhì) |
6140-12-1 |
詳細(xì)
|
| 6-Keto Fulvestrant (25 mg) ((7Alpha,17Beta)-7-[9-[4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-3,17Beta-dihydroxyestra-1,3,5(10)-trien-6-one; 7Alpha-{9-[(4,4,5,5,5,-Pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-6-one-3,17Beta-diol) |
氟維司群EP雜質(zhì)F |
2858589-78-1 |
詳細(xì)
|
| 4-Hydroxy Duloxetine Acetate (25 mg) ((S)-4-(3-(methylamino)-1-(thiophen-2-yl)propoxy)naphthalen-1-ol, acetate) |
|
2705426-23-7 |
詳細(xì)
|
| 7-Chloromethyl Drospirenone (10 mg) |
7-ChloroMethyl Drospirenone |
932388-90-4 |
詳細(xì)
|
| Linagliptin impurity 16 |
利拉利汀雜質(zhì)16 |
1955514-80-3 |
詳細(xì)
|
| Olmesartan Impurity G |
5-(4-(二溴甲基)-[1,1-二聯(lián)苯]-2-基)-1-三苯甲基-1H-四唑
（奧美沙坦酯雜質(zhì)G） |
358685-13-9 |
詳細(xì)
|
| 6-Ethylpyrimidine-2,4-diamine (25 mg) (6-Ethylpyrimidine-2,4-diamine) |
2,4-二氨基-6-乙基嘧啶 |
514854-12-7 |
詳細(xì)
|
| 3-Benzyl-4-Heptanone (5 x 0.5 mL) |
3-芐基-4-庚酮 |
7492-37-7 |
詳細(xì)
|
| 1H-Imidazole-4-carboxylicacid, 2,3-dihydro-3-(1-phenylethyl)-2-thioxo-, methyl ester |
|
|
詳細(xì)
|
| 1,2-Dinitroglycerin (2 ampules x 1 mL) |
1,2-二甘油 |
621-65-8 |
詳細(xì)
|
| N-Phthalimide-linagliptin |
N-鄰苯二甲酰亞胺-利格列汀 |
886588-63-2 |
詳細(xì)
|
| N,S-Carboxymethyl Cysteine |
N,S-（二羧甲基）半胱氨酸 |
907565-13-3 |
詳細(xì)
|
| Olmesartan Medoxomil Impurity 17 |
美沙坦酯雜質(zhì)17 |
1418133-31-9 |
詳細(xì)
|
| 1H-Imidazole-4,5-dicarboxylic acid, 2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]- |
奧美沙坦酯雜質(zhì) |
1350442-05-5 |
詳細(xì)
|
| 6-Hydroxynicotinic Acid (50 mg) |
6-羥基煙酸 |
5006-66-6 |
詳細(xì)
|
| INDEX NAME NOT YET ASSIGNED |
利格列汀雜質(zhì) |
2748381-67-9 |
詳細(xì)
|
| 2-Monobromo Aripiprazole Hydrochloride (25 mg) (7-(4-(4-(2-bromophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one, hydrochloride) |
阿立哌唑雜質(zhì) 33 HCL (OPC 14714 HCL) |
2748462-55-5 |
詳細(xì)
|
| 4-Phenylbutyl(benzyl)amine hydrochloride (25 mg) (N-benzyl-4-phenylbutan-1-amine, hydrochloride) |
沙美特羅雜質(zhì) |
144391-74-2 |
詳細(xì)
|
| 3-Amino-2,4,6-triiodobenzoic Acid (50 mg) |
3-氨基-2,4,6-三碘苯甲酸 |
3119-15-1 |
詳細(xì)
|
| 4-Nitrosopiperazine-1-ethanol Solution (1 mL (1 mg/mL)) (2-(4-Nitrosopiperazin-1-yl)ethan-1-ol) |
阿立哌唑雜質(zhì)26 |
48121-20-6 |
詳細(xì)
|
| 2-Oxo R-Clopidogrel (10 mg) (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate) |
氯吡格雷雜質(zhì) |
1360923-54-1 |
詳細(xì)
|
| 16Alpha-Hydroxy Prednisolone-9(11)-ene Diacetate (25 mg) (2-((8S,10S,13S,14S,16R,17S)-16-acetoxy-17-hydroxy-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate) |
布地奈德雜質(zhì)18 |
95943-95-6 |
詳細(xì)
|
| 4-Hydroxyindole (25 mg) (1H-Indol-4-ol) |
4-羥基吲哚 |
2380-94-1 |
詳細(xì)
|
| 4-Methylacetophenone (1-(4-Methylphenyl)-1-ethanone (4'-Methylacetophenone)) |
4'-甲基苯乙酮 |
122-00-9 |
詳細(xì)
|
| 1,3-Propanediol (1 mL) |
1,3-丙二醇 |
504-63-2 |
詳細(xì)
|
| (S)-1-N-CBZ-2-CYANO-PYRROLIDINE |
(S)-1-N-芐氧羰基-2-氰基吡咯烷（維格列汀雜質(zhì)） |
63808-36-6 |
詳細(xì)
|
| 1-Benzhydryl-4-nitrosopiperazine Solution (1 mL (1 mg/mL)) (1-benzhydryl-4-nitrosopiperazine) |
N-亞硝基桂利嗪EP雜質(zhì)A |
1698-25-5 |
詳細(xì)
|
| 3-(1-PHENYL-ETHYL)-3H-IMIDAZOLE-4-CARBOXYLIC ACID |
依托咪酯雜質(zhì)A |
3157-27-5 |
詳細(xì)
|
| Vildagliptin Related Compound A |
維格列汀雜質(zhì)A |
741657-02-3 |
詳細(xì)
|
| methyl (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylate |
(R)-1-(1-苯基乙基)-1H-咪唑-5-羧酸甲酯 |
61045-91-8 |
詳細(xì)
|
| (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate |
( 4-(2-羥異丙基)-2-丙基-1H-咪唑-5-甲酸(5-甲基-2-氧雜-1,3-二氧-4-甲基）酯(奧美沙坦酯雜質(zhì)) |
144978-05-2 |
詳細(xì)
|
| Linagliptin Impurity 33 |
利格列汀雜質(zhì)33 |
2443735-53-1 |
詳細(xì)
|
| 23-EPI-26-Deoxyactein (20 mg) |
23-表-26-去羥基阿科特素 |
501938-01-8 |
詳細(xì)
|
| 3-Amino-4-tolylsulfonamide (25 mg) (3-amino-4-methylbenzenesulfonamide) |
3-氨基-4-甲基苯磺胺 |
6274-28-8 |
詳細(xì)
|
| (E)-Thiothixene (100 mg) |
(E)-THIOTHIXENE |
3313-27-7 |
詳細(xì)
|
| 2-Acetylpyridine (1 g) |
2-乙?；拎?/td>
| 1122-62-9 |
詳細(xì)
|
| (2S)-1-(2-chloroacetyl)-N,N-dimethylpyrrolidine-2-carboxamide |
維格列汀的雜質(zhì) |
2381862-94-6 |
詳細(xì)
|
| 5-Phenylhydantoin (100 mg) |
5-苯基海因 |
89-24-7 |
詳細(xì)
|
| 6'-DesMethyl-6'-Methylhydroxy Etoricoxib |
依托考昔雜質(zhì)K |
349536-41-0 |
詳細(xì)
|
| Etomidate Impurity 20 |
S-(-)-2-巰基依托咪酯 |
112421-33-7 |
詳細(xì)
|
| 6,6'-Dinicotinic Acid (50 mg) |
2,2'-聯(lián)吡啶-5,5'-二羧酸 |
1802-30-8 |
詳細(xì)
|
| Vildagliptin Carboxylic Acid Methyl Ester |
維達(dá)列汀羧酸甲酯 |
948574-56-9 |
詳細(xì)
|
| R(+)-TRANS[ETHOXY CARBONYLMETHYL]-1-PHENYLETHYLAMINE |
依托咪酯中間體I |
66512-37-6 |
詳細(xì)
|
| INDEX NAME NOT YET ASSIGNED |
利格列汀雜質(zhì) |
2748491-45-2 |
詳細(xì)
|
| 2-Mononitroglycerin (2 ampules x 1 mL) |
2-硝基丙三醇 |
620-12-2 |
詳細(xì)
|
| 6-Methyl-4-phenylchromanol (25 mg) (6-Methyl-4-phenylchroman-2-ol) |
托特羅定乳醇雜質(zhì) |
209747-04-6 |
詳細(xì)
|
| 2E, 4E-Hexadienoic Acid Isobutylamide (25 mg) |
HEXADIENOIC ACID ISOBUTYLAMIDE, 2,4-(P) (AHP Verified) |
65937-49-7 |
詳細(xì)
|
| 3-Acetyl-11-Keto-Beta-Boswellic Acid (20 mg) |
11-羰基-Β-乙酰乳香酸 |
67416-61-9 |
詳細(xì)
|
| 1,3-Dimethyl-6-nitroindazole (25 mg) (1,3-dimethyl-6-nitro-1H-indazole) |
1,3-二甲基-6-硝基-1H-吲唑 |
1354224-47-7 |
詳細(xì)
|
| Olmesartan Impurity 9 |
奧美沙坦酯雜質(zhì)9 |
849206-42-4 |
詳細(xì)
|
| Olmesartan Medoxomil Impurity G |
奧美沙坦MEDOXOMIL雜質(zhì)G |
761404-82-4 |
詳細(xì)
|
| 2,3-Dimethyl-2,3-butanediamine Dihydrochloride (25 mg) (2,3-dimethylbutane-2,3-diamine, hydrochloride) |
2,3-二甲基-2,3-丁二胺二鹽酸鹽 |
75804-28-3 |
詳細(xì)
|
| 6-Methyl-4-phenylchromanone (25 mg) (6-Methyl-4-phenylchroman-2-one) |
6-甲基-4-苯基色滿-2-酮 |
40546-94-9 |
詳細(xì)
|
| 4-Nitroso-1-(4-fluorobenzoyl)piperazine Solution (1 mL (1 mg/mL)) ((4-fluorophenyl)(4-nitrosopiperazin-1-yl)methanone) |
|
2892260-28-3 |
詳細(xì)
|
| 5-O-Methylvisammioside (25 mg) |
5-O-甲基維斯阿米醇苷 |
84272-85-5 |
詳細(xì)
|
| 12-Hydroxystearic Acid (200 mg) |
12-羥基硬脂酸 |
106-14-9 |
詳細(xì)
|
| 4-Epianhydrotetracycline Hydrochloride (50 mg) |
4-差向脫水四環(huán)素 |
4465-65-0 |
詳細(xì)
|
| 6alpha-Hydroxybudesonide (25 mg) ((2S,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2,7-Dihydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one) |
6-Α-羥基布地奈德 |
577777-51-6 |
詳細(xì)
|
| 5-Me Bz dC Beta-Cyanoethyl Phosphoramidite (500 mg) (5-Methyl-5'-O-Dimethoxytrityl-N4-benzoyl-2'-deoxycytidine-3'-O-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite) |
Bz-5-ME-2'-脫氧胞苷亞磷酰胺單體 |
105931-57-5 |
詳細(xì)
|
| 3-Chloropropiophenone (25 mg) (1-Phenyl-3-chloro-1-propanone) |
3-氯代苯丙酮 |
936-59-4 |
詳細(xì)
|
| Linagliptin Impurity 28 |
利格列汀雜質(zhì)28 |
2074688-84-7 |
詳細(xì)
|
| Vildagliptin Impurity 57 |
維格列汀雜質(zhì)57 |
913980-23-1 |
詳細(xì)
|
| 5-Hydroxy Ivabradine (25 mg) (3-(3-((((S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-5-hydroxy-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one) |
2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-5-hydroxy-7,8-dimethoxy- |
2253977-80-7 |
詳細(xì)
|
| 1-(2-Methoxyphenyl)-4-nitrosopiperazine Solution (1 mL (1 mg/mL)) (1-(2-Methoxyphenyl)-4-nitrosopiperazine) |
N-Nitroso-1-(2-methoxyphenyl)-piperazine |
2219339-64-5 |
詳細(xì)
|
| 4-Thiomorpholineacetic acid, 3-carboxy-5-oxo-, (3R)- |
(3R) - 3- 羧基- 5- 氧代- 4- 硫代嗎啉乙酸 |
1601460-92-7 |
詳細(xì)
|
| Vildagliptin Impurity 13 |
維達(dá)列汀雜質(zhì)13 |
2577-48-2 |
詳細(xì)
|
| Linagliptin impurity KH-2 |
N-(2-乙酰基苯基)-2-(8-溴-7-(丁-2-炔-1-基)-3-甲基-2,6-二氧代-2,3,6,7-四氫-1H--嘌呤-1-基)乙酰胺(利格列汀雜質(zhì)) |
2279114-31-5 |
詳細(xì)
|
| 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-[(4-methyl-2-quinazolinyl)methoxy]-1-[(4-methyl-2-quinazolinyl)methyl]- |
利格列汀雜質(zhì) |
2469626-53-5 |
詳細(xì)
|